Ablation of PI3K blocks BCR-ABL leukemogenesis in mice, and a dual PI3K/mTOR inhibitor prevents expansion of human BCR-ABL+ leukemia cells.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples